Colgate-Palmolive's Price Target Reduced to $90 by TD Cowen Amid Restructuring Plan
ByAinvest
Wednesday, Aug 6, 2025 10:46 am ET1min read
CL--
The company's organic sales growth was 1.8%, driven by a 0.2% drop in organic volume and a 2% improvement in pricing. The company maintained its leadership in the toothpaste market with a 41.1% global market share year to date and continued to lead the manual toothbrush market with a 32.4% global market share year to date [1].
Colgate-Palmolive's gross profit margin decreased by 70 basis points to 60.1%, and its adjusted operating profit margin contracted by 80 basis points to 21.3% [1]. The company's cash and cash equivalents stood at $1.22 billion, and its total debt was $8.8 billion [1].
Despite the positive results, Colgate-Palmolive lowered its full-year organic sales growth forecast to the lower end of its previous 2-4% guidance range. The company expects net sales to grow in low single digits, with a flat to low-single-digit adverse impact of foreign exchange. On a non-GAAP (Base Business) basis, Colgate expects gross profit margin and advertising to be nearly flat as a percentage of sales, and EPS to grow by low single digits [1].
In response to the results, TD Cowen lowered its price target to $90 from $100 and maintains a Buy rating. The company also announced a three-year restructuring program to optimize the supply chain and streamline the organization [2].
References:
[1] https://finance.yahoo.com/news/colgate-tops-q2-earnings-sales-151300813.html
[2] https://site.financialmodelingprep.com/market-news/colgate-palmolive-q2-2025-earnings-adjusts-sales-growth-forecast
Colgate-Palmolive's 2Q results were broadly in line, but management lowered sales guidance to the lower end of the 2-4% range. TD Cowen has lowered its price target to $90 from $100 and maintains a Buy rating. The company announced a three-year restructuring program to optimize the supply chain and streamline the organization.
Colgate-Palmolive Company (CL) reported its second-quarter 2025 earnings, with results broadly in line with expectations. The company saw earnings per share (EPS) of $0.92, up 1% from the prior-year period, and net sales of $5.11 billion, up 1% year over year [1].The company's organic sales growth was 1.8%, driven by a 0.2% drop in organic volume and a 2% improvement in pricing. The company maintained its leadership in the toothpaste market with a 41.1% global market share year to date and continued to lead the manual toothbrush market with a 32.4% global market share year to date [1].
Colgate-Palmolive's gross profit margin decreased by 70 basis points to 60.1%, and its adjusted operating profit margin contracted by 80 basis points to 21.3% [1]. The company's cash and cash equivalents stood at $1.22 billion, and its total debt was $8.8 billion [1].
Despite the positive results, Colgate-Palmolive lowered its full-year organic sales growth forecast to the lower end of its previous 2-4% guidance range. The company expects net sales to grow in low single digits, with a flat to low-single-digit adverse impact of foreign exchange. On a non-GAAP (Base Business) basis, Colgate expects gross profit margin and advertising to be nearly flat as a percentage of sales, and EPS to grow by low single digits [1].
In response to the results, TD Cowen lowered its price target to $90 from $100 and maintains a Buy rating. The company also announced a three-year restructuring program to optimize the supply chain and streamline the organization [2].
References:
[1] https://finance.yahoo.com/news/colgate-tops-q2-earnings-sales-151300813.html
[2] https://site.financialmodelingprep.com/market-news/colgate-palmolive-q2-2025-earnings-adjusts-sales-growth-forecast
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet